Tissue Regenix Group
Stock Forecast, Prediction & Price Target
Tissue Regenix Group Financial Estimates
Tissue Regenix Group Revenue Estimates
Tissue Regenix Group EBITDA Estimates
Tissue Regenix Group Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| £14.35M N/A | £19.87M 38.39% | £29.49M 48.42% | Avg: £31.25M Low: £27.66M High: £34.83M avg. 5.96% | |||
Net Income
% change YoY
| £-3.48M N/A | £-2.18M 37.20% | £-1.71M 21.70% | Avg: £607.36K Low: £584.00K High: £636.56K avg. 135.45% | |||
EBITDA
% change YoY
| £-2.18M N/A | £-690.87K 68.44% | £446K 164.55% | Avg: £-5.62M Low: £-6.26M High: £-4.97M avg. -1360.72% | |||
EPS
% change YoY
| -$0.05 N/A | -$0.03 37.17% | -$0.02 21.86% | Avg: $0.01 Low: $0.01 High: $0.01 avg. 135.49% | |||
Operating Expenses
% change YoY
| £8.61M N/A | £10.75M 24.80% | £14.43M 34.24% | Avg: £19.60M Low: £17.35M High: £21.85M avg. 35.82% | |||
FAQ
What is Tissue Regenix Group stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 135.45% in 2025-2025.
We have gathered data from 2 analysts. Their low estimate is 584.00K, average is 607.36K and high is 636.56K.
What is Tissue Regenix Group stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5.96% in 2025-2025.
We have gathered data from 2 analysts. Their low revenue estimate is £27.66M, average is £31.25M and high is £34.83M.
What is Tissue Regenix Group stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 135.49% in 2025-2025.
We have gathered data from 2 analysts. Their low earnings per share estimate is $0.01, average is $0.01 and high is £0.00.